Interleukin-6 Receptor Antagonist [EPC]

Interleukin-6 Receptor Antagonist [EPC] was reported 138631 times

Drugs of the Interleukin-6 Receptor Antagonist [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 HUMAN ANTICHIMERIC ANTIBODY POSITIVE 310 0.9226
1 DISABILITY ASSESSMENT SCALE SCORE INCREASED 267 0.8697
2 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 6111 0.8521
3 SWOLLEN JOINT COUNT INCREASED 2646 0.8289
4 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 552 0.8263
5 RHEUMATOID FACTOR POSITIVE 4690 0.8111
6 RHEUMATIC FEVER 3526 0.7902
7 RHEUMATOID FACTOR NEGATIVE 138 0.7886
8 PEMPHIGUS 9469 0.7566
9 DEEP VEIN THROMBOSIS POSTOPERATIVE 1503 0.7504
10 RED BLOOD CELL SEDIMENTATION RATE 209 0.7491
11 C-REACTIVE PROTEIN 666 0.7184
12 DUODENAL ULCER PERFORATION 5347 0.7183
13 LUPUS VULGARIS 903 0.7167
14 SWOLLEN JOINT COUNT 164 0.6560
15 GRIP STRENGTH 149 0.6507
16 FACET JOINT SYNDROME 2100 0.6444
17 GRANULOMA SKIN 525 0.6395
18 HEPATIC ENZYME 95 0.6376
19 HAND DEFORMITY 8243 0.6278
20 C-REACTIVE PROTEIN ABNORMAL 3887 0.6054
21 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 1387 0.6015
22 SYNOVITIS 10755 0.5959
23 MUSCULOSKELETAL DEFORMITY 135 0.5769
24 X-RAY ABNORMAL 989 0.5525
25 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 1103 0.5318
26 MUSCLE INJURY 4327 0.5217
27 HELICOBACTER INFECTION 5346 0.5196
28 BODY HEIGHT BELOW NORMAL 323 0.5023
29 DISLOCATION OF VERTEBRA 1128 0.4941
30 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 3206 0.4932
31 PRESBYACUSIS 147 0.4773
32 FOLLICULITIS 4893 0.4661
33 BONE EROSION 1617 0.4568
34 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 245 0.4367
35 RETINITIS 750 0.4338
36 JOINT LAXITY 131 0.4338
37 BLOOD PARATHYROID HORMONE DECREASED 612 0.4127
38 CONTRAINDICATED PRODUCT ADMINISTERED 12411 0.4095
39 ANTICIPATORY ANXIETY 110 0.4044
40 GLOSSODYNIA 8780 0.3918
41 PERICARDITIS 6498 0.3864
42 SERONEGATIVE ARTHRITIS 442 0.3857
43 PERIPHERAL VENOUS DISEASE 1523 0.3726
44 RHEUMATOID NODULE 1011 0.3667
45 SHORT STATURE 96 0.3664
46 BLOOD IRON ABNORMAL 348 0.3562
47 BLOOD PRESSURE DIASTOLIC ABNORMAL 896 0.3519
48 DRUG TOLERANCE DECREASED 945 0.3362
49 BLOOD PRESSURE SYSTOLIC ABNORMAL 815 0.3294
50 ANKLE ARTHROPLASTY 113 0.3113
51 JOINT DESTRUCTION 473 0.3040
52 INTESTINAL SEPSIS 78 0.2977
53 SYSTEMIC LUPUS ERYTHEMATOSUS 10087 0.2839
54 PANNICULITIS 685 0.2828
55 LOOSE BODY IN JOINT 74 0.2782
56 HYPOCHOLESTEROLAEMIA 96 0.2720
57 WOUND 7503 0.2682
58 BREAST CANCER STAGE III 1647 0.2540
59 JUVENILE IDIOPATHIC ARTHRITIS 615 0.2512
60 RED BLOOD CELL SEDIMENTATION RATE INCREASED 2759 0.2491
61 PORPHYRIA ACUTE 344 0.2397
62 TEMPERATURE REGULATION DISORDER 530 0.2377
63 ONYCHOMADESIS 973 0.2316
64 BURSITIS 2770 0.2281
65 GRIP STRENGTH DECREASED 1994 0.2263
66 GIANT CELL ARTERITIS 184 0.2214
67 LIP DRY 2012 0.2213
68 IRRITABLE BOWEL SYNDROME 4737 0.2207
69 RHEUMATOID ARTHRITIS 24972 0.2197
70 JOINT RANGE OF MOTION DECREASED 2874 0.2141
71 ONYCHOMYCOSIS 925 0.2106
72 HYPERCHOLESTEROLAEMIA 2027 0.2097
73 OVERLAP SYNDROME 146 0.2086
74 RHEUMATOID LUNG 198 0.2073
75 AMAUROSIS FUGAX 222 0.2061
76 ARTHROPATHY 11225 0.2018
77 WOUND INFECTION 2097 0.1913
78 THERAPEUTIC PRODUCT EFFECT DECREASED 8256 0.1841
79 TENOSYNOVITIS 497 0.1800
80 FIBROMYALGIA 4281 0.1759
81 PLEURAL THICKENING 119 0.1740
82 BONE CYST 158 0.1684
83 BLEPHAROSPASM 1054 0.1672
84 IMPAIRED HEALING 5439 0.1655
85 FINGER DEFORMITY 794 0.1637
86 JOINT ANKYLOSIS 93 0.1637
87 ANTIBODY TEST POSITIVE 269 0.1620
88 AUTOIMMUNE DISORDER 1555 0.1594
89 LIVE BIRTH 1331 0.1589
90 JOINT SWELLING 18640 0.1543
91 PLEURAL FIBROSIS 152 0.1492
92 INFUSION RELATED REACTION 9695 0.1461
93 LIVER INJURY 3550 0.1445
94 WRIST DEFORMITY 88 0.1431
95 INTERLEUKIN LEVEL INCREASED 78 0.1413
96 SYSTEMIC LUPUS ERYTHEMATOSUS RASH 112 0.1404
97 MEAN PLATELET VOLUME DECREASED 117 0.1395
98 DRUG INTOLERANCE 13383 0.1384
99 VASCULAR ACCESS COMPLICATION 111 0.1370
100 INFUSION SITE REACTION 408 0.1365
101 ARTHRODESIS 138 0.1356
102 NAIL DISORDER 1178 0.1345
103 SCIATICA 2145 0.1344
104 POLYARTHRITIS 709 0.1344
105 HEPATIC ENZYME INCREASED 9109 0.1335
106 COELIAC DISEASE 1305 0.1329
107 JOINT ARTHROPLASTY 238 0.1328
108 OBESITY 2100 0.1317
109 LOWER RESPIRATORY TRACT INFECTION 5919 0.1300
110 BLOOD MAGNESIUM INCREASED 117 0.1297
111 MATERNAL EXPOSURE TIMING UNSPECIFIED 482 0.1282
112 TREATMENT FAILURE 10385 0.1252
113 TYPE 2 DIABETES MELLITUS 4167 0.1236
114 LIMB DEFORMITY 196 0.1233
115 PULMONARY FIBROSIS 2341 0.1219
116 FOOT DEFORMITY 1345 0.1212
117 C-REACTIVE PROTEIN INCREASED 4401 0.1208
118 ALLERGY TO CHEMICALS 150 0.1204
119 SOFT TISSUE DISORDER 133 0.1199
120 DEATH NEONATAL 166 0.1193
121 HIP ARTHROPLASTY 1821 0.1188
122 INTERCEPTED PRODUCT STORAGE ERROR 420 0.1176
123 SWELLING 10921 0.1166
124 C-REACTIVE PROTEIN DECREASED 76 0.1164
125 PSORIATIC ARTHROPATHY 4724 0.1163
126 ENTHESOPATHY 180 0.1150
127 EXOSTOSIS 1020 0.1116
128 SKIN NECROSIS 577 0.1111
129 BLOOD PRESSURE DIASTOLIC INCREASED 513 0.1110
130 BLOOD PRESSURE DIASTOLIC DECREASED 811 0.1098
131 HYPOFIBRINOGENAEMIA 107 0.1079
132 PRESCRIBED OVERDOSE 1985 0.1025
133 INVESTIGATION ABNORMAL 146 0.1015
134 KNEE ARTHROPLASTY 2127 0.1009
135 BLOOD CHOLESTEROL INCREASED 4669 0.1001
136 DISCOMFORT 6101 0.0999
137 POLYMYALGIA RHEUMATICA 315 0.0991
138 APPARENT DEATH 355 0.0985
139 BLISTER 5507 0.0980
140 STOMATITIS 5860 0.0965
141 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 4617 0.0960
142 LUPUS-LIKE SYNDROME 871 0.0959
143 DRUG SPECIFIC ANTIBODY 128 0.0934
144 FOOD ALLERGY 719 0.0931
145 PUSTULAR PSORIASIS 317 0.0922
146 LOWER RESPIRATORY TRACT CONGESTION 156 0.0917
147 DRUG TOLERANCE 455 0.0898
148 WALKING AID USER 592 0.0897
149 PRODUCT LABEL CONFUSION 523 0.0896
150 OSTEOARTHRITIS 3750 0.0884
151 IMMUNODEFICIENCY 1311 0.0879
152 GAIT INABILITY 2911 0.0870
153 MUSCULOSKELETAL STIFFNESS 7596 0.0866
154 BACK INJURY 938 0.0862
155 ALANINE AMINOTRANSFERASE ABNORMAL 180 0.0853
156 BRONCHITIS CHRONIC 208 0.0851
157 ILL-DEFINED DISORDER 5171 0.0850
158 LOWER LIMB FRACTURE 1632 0.0849
159 MEAN CELL VOLUME DECREASED 130 0.0843
160 JOINT DISLOCATION 891 0.0842
161 INFLAMMATION 4325 0.0837
162 INFECTED BITE 70 0.0824
163 JOINT STIFFNESS 2149 0.0818
164 LIVER FUNCTION TEST INCREASED 1743 0.0811
165 BLOOD PRESSURE SYSTOLIC INCREASED 1507 0.0772
166 MEAN CELL HAEMOGLOBIN DECREASED 141 0.0770
167 MOBILITY DECREASED 5525 0.0768
168 RHEUMATOID FACTOR INCREASED 85 0.0761
169 NIGHT SWEATS 2454 0.0761
170 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 565 0.0752
171 PNEUMONIA VIRAL 240 0.0752
172 MATERNAL EXPOSURE DURING PREGNANCY 6622 0.0742
173 IMMOBILE 323 0.0739
174 OSTEOPOROTIC FRACTURE 141 0.0736
175 SPONDYLITIS 264 0.0725
176 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 426 0.0719
177 SYNOVIAL CYST 332 0.0718
178 INTERCEPTED MEDICATION ERROR 333 0.0718
179 ORAL MUCOSAL EXFOLIATION 107 0.0707
180 BREAST CANCER STAGE II 583 0.0700
181 RETINAL TOXICITY 72 0.0699
182 FINE MOTOR SKILL DYSFUNCTION 200 0.0690
183 EAR PAIN 1335 0.0686
184 EYE INJURY 208 0.0684
185 JOINT EFFUSION 470 0.0681
186 PRESCRIBED UNDERDOSE 1352 0.0677
187 SURGICAL FAILURE 78 0.0674
188 PRURITUS ALLERGIC 78 0.0668
189 SCLERITIS 107 0.0667
190 ULCER HAEMORRHAGE 448 0.0661
191 DIVERTICULAR PERFORATION 136 0.0660
192 ABDOMINAL DISCOMFORT 11061 0.0659
193 LIMB MASS 144 0.0655
194 MUSCULOSKELETAL PAIN 3368 0.0642
195 INTENTIONAL PRODUCT USE ISSUE 5604 0.0639
196 CONGENITAL ANOMALY 492 0.0635
197 PERIPHERAL SWELLING 9579 0.0621
198 FOETAL DEATH 322 0.0620
199 DEFORMITY 578 0.0618
200 INFECTION 8930 0.0616
201 PULMONARY TOXICITY 435 0.0614
202 DEMYELINATION 252 0.0614
203 DRUG ERUPTION 1081 0.0609
204 SINUSITIS 6248 0.0609
205 SYSTEMIC CANDIDA 153 0.0609
206 HEPATIC CIRRHOSIS 1145 0.0609
207 ARTHRITIS BACTERIAL 249 0.0606
208 RASH VESICULAR 290 0.0599
209 URINARY TRACT DISORDER 267 0.0592
210 BODY TEMPERATURE DECREASED 580 0.0589
211 DRUG DELIVERY SYSTEM MALFUNCTION 297 0.0580
212 HYPERSENSITIVITY 10771 0.0580
213 SKIN ULCER 1492 0.0577
214 MUSCLE SPASTICITY 705 0.0573
215 ALOPECIA 11244 0.0572
216 DIVERTICULITIS 1582 0.0570
217 ARTHRITIS INFECTIVE 262 0.0564
218 GASTROINTESTINAL DISORDER 5041 0.0562
219 INFECTIOUS PLEURAL EFFUSION 85 0.0558
220 SLEEP DISORDER 3883 0.0550
221 WHEELCHAIR USER 241 0.0542
222 LIVER DISORDER 2400 0.0541
223 HYPERCALCAEMIA 667 0.0540
224 HISTIOCYTOSIS HAEMATOPHAGIC 160 0.0538
225 ADRENAL INSUFFICIENCY 645 0.0531
226 HEPATITIS 1353 0.0528
227 LUNG DISORDER 2571 0.0524
228 NODULE 681 0.0521
229 GASTROINTESTINAL PERFORATION 215 0.0517
230 SPINAL COLUMN INJURY 115 0.0515
231 THERAPY NON-RESPONDER 2298 0.0511
232 PRERENAL FAILURE 72 0.0511
233 BASAL CELL CARCINOMA 791 0.0506
234 ARTHRALGIA 21017 0.0505
235 COLITIS MICROSCOPIC 239 0.0504
236 CREPITATIONS 150 0.0503
237 OSTEOPOROSIS 2047 0.0497
238 SPINAL STENOSIS 205 0.0496
239 WHEEZING 2928 0.0493
240 MONOCYTE COUNT INCREASED 179 0.0492
241 CUSHINGOID 158 0.0492
242 ULCER 782 0.0491
243 DEAFNESS NEUROSENSORY 161 0.0489
244 INJURY 3405 0.0484
245 CONTUSION 4651 0.0483
246 PNEUMONIA FUNGAL 188 0.0476
247 NASAL ULCER 75 0.0470
248 CYTOKINE RELEASE SYNDROME 940 0.0468
249 CUTANEOUS VASCULITIS 171 0.0468
250 EPIGASTRIC DISCOMFORT 181 0.0463
251 BLOOD PRESSURE FLUCTUATION 1112 0.0463
252 ARTHRITIS 3635 0.0462
253 GENERAL PHYSICAL HEALTH DETERIORATION 5310 0.0458
254 SPINAL FUSION SURGERY 186 0.0458
255 JOINT NOISE 90 0.0458
256 NEOPLASM SKIN 71 0.0457
257 RHEUMATIC DISORDER 88 0.0455
258 BODY TEMPERATURE INCREASED 925 0.0453
259 NORMAL NEWBORN 243 0.0447
260 INTESTINAL POLYP 73 0.0443
261 OEDEMA 2404 0.0443
262 EXPOSURE DURING PREGNANCY 2746 0.0441
263 TASTE DISORDER 893 0.0440
264 NASOPHARYNGITIS 8056 0.0437
265 INJECTION SITE HYPERSENSITIVITY 136 0.0435
266 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 3089 0.0434
267 SKIN PAPILLOMA 174 0.0433
268 ROAD TRAFFIC ACCIDENT 1810 0.0432
269 PHYSICAL DISABILITY 191 0.0432
270 DRUG-INDUCED LIVER INJURY 1355 0.0431
271 WHITE BLOOD CELL COUNT ABNORMAL 272 0.0426
272 PNEUMONIA BACTERIAL 391 0.0426
273 DISABILITY 842 0.0425
274 ADVERSE REACTION 555 0.0418
275 RESPIRATORY DISORDER 1252 0.0418
276 BRONCHOPULMONARY ASPERGILLOSIS 323 0.0416
277 VIRAL UPPER RESPIRATORY TRACT INFECTION 197 0.0414
278 INFECTED SKIN ULCER 78 0.0412
279 UPPER RESPIRATORY TRACT INFECTION 1882 0.0407
280 EAR INFECTION 1056 0.0396
281 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 680 0.0396
282 EPILEPSY 1210 0.0395
283 PAIN 24192 0.0393
284 NO ADVERSE EVENT 7096 0.0391
285 FOOT OPERATION 193 0.0390
286 JOINT LOCK 109 0.0384
287 TUBERCULIN TEST POSITIVE 96 0.0379
288 MYOSITIS 339 0.0377
289 JOINT INJURY 806 0.0377
290 PREGNANCY 755 0.0377
291 GROWTH RETARDATION 111 0.0377
292 OSTEOLYSIS 77 0.0376
293 CONDITION AGGRAVATED 11411 0.0375
294 PRODUCT USE ISSUE 6982 0.0371
295 COVID-19 PNEUMONIA 438 0.0371
296 HEPATIC ENZYME ABNORMAL 185 0.0371
297 PHARYNGITIS 459 0.0370
298 BLOOD PRESSURE SYSTOLIC DECREASED 165 0.0362
299 APHTHOUS ULCER 281 0.0362
300 LOCALISED INFECTION 865 0.0357
301 DELIRIUM 1238 0.0356
302 GASTROINTESTINAL TOXICITY 169 0.0351
303 WEIGHT INCREASED 7790 0.0348
304 SKIN LACERATION 378 0.0347
305 LIPIDS INCREASED 70 0.0347
306 SUSPECTED OFF LABEL USE 155 0.0343
307 NECK PAIN 1913 0.0342
308 NEUROGENIC BLADDER 72 0.0341
309 HERPES ZOSTER 1958 0.0340
310 HEART RATE DECREASED 1190 0.0339
311 RASH 14724 0.0337
312 URTICARIA 5598 0.0334
313 THERAPEUTIC RESPONSE DECREASED 2020 0.0333
314 HAEMORRHAGIC STROKE 258 0.0330
315 HYPERTENSION 6901 0.0325
316 INTERSTITIAL LUNG DISEASE 1563 0.0322
317 DRY MOUTH 2616 0.0322
318 INJECTION SITE REACTION 2198 0.0319
319 HYPERTRANSAMINASAEMIA 222 0.0319
320 HAEMATOLOGICAL INFECTION 77 0.0315
321 GENERAL SYMPTOM 236 0.0315
322 CARDIOTOXICITY 279 0.0312
323 MOUTH ULCERATION 659 0.0312
324 ANTINUCLEAR ANTIBODY POSITIVE 101 0.0311
325 CONFUSIONAL STATE 5019 0.0310
326 DEVICE DEFECTIVE 535 0.0308
327 TOOTH INFECTION 404 0.0306
328 MUSCULOSKELETAL DISORDER 582 0.0305
329 SHOULDER ARTHROPLASTY 82 0.0304
330 PULMONARY MASS 453 0.0304
331 NECK MASS 86 0.0304
332 DRUG INEFFECTIVE 39318 0.0298
333 NECROTISING FASCIITIS 105 0.0298
334 OXYGEN SATURATION DECREASED 1665 0.0296
335 PULMONARY THROMBOSIS 322 0.0295
336 HEPATIC STEATOSIS 550 0.0295
337 HEPATOTOXICITY 653 0.0293
338 POOR VENOUS ACCESS 303 0.0293
339 SKIN ABRASION 138 0.0292
340 HYPOAESTHESIA 4274 0.0285
341 PLEURISY 169 0.0284
342 ORAL HERPES 555 0.0284
343 TONGUE ULCERATION 96 0.0284
344 RED CELL DISTRIBUTION WIDTH INCREASED 118 0.0284
345 WEIGHT FLUCTUATION 297 0.0284
346 INTESTINAL PERFORATION 318 0.0283
347 ABSCESS LIMB 120 0.0281
348 TERMINAL STATE 187 0.0279
349 SEPTIC SHOCK 1213 0.0278
350 DRUG USE DISORDER 234 0.0278
351 RESPIRATORY RATE INCREASED 246 0.0277
352 HYPOGAMMAGLOBULINAEMIA 181 0.0275
353 BREATH SOUNDS ABNORMAL 135 0.0274
354 PRODUCT TEMPERATURE EXCURSION ISSUE 140 0.0272
355 DYSPEPSIA 2649 0.0269
356 TONGUE DISORDER 193 0.0266
357 TENDERNESS 273 0.0262
358 GASTRIC INFECTION 100 0.0261
359 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 69 0.0259
360 ULCERATIVE KERATITIS 71 0.0259
361 OSTEOMYELITIS 469 0.0259
362 INFLAMMATORY MARKER INCREASED 128 0.0258
363 LYMPHOPROLIFERATIVE DISORDER 75 0.0255
364 CYST 314 0.0253
365 LARGE INTESTINE PERFORATION 175 0.0252
366 ASPERGILLUS INFECTION 165 0.0251
367 SENSITIVITY TO WEATHER CHANGE 132 0.0251
368 PAIN IN EXTREMITY 7328 0.0248
369 BACK DISORDER 403 0.0248
370 MASS 345 0.0247
371 IMPAIRED WORK ABILITY 525 0.0245
372 GRANULOMA 85 0.0245
373 OFF LABEL USE 21459 0.0245
374 DERMATITIS ALLERGIC 306 0.0243
375 LIGAMENT SPRAIN 237 0.0239
376 BRONCHIECTASIS 161 0.0239
377 INJECTION SITE INFLAMMATION 119 0.0239
378 MIGRAINE 2276 0.0238
379 TOOTHACHE 431 0.0238
380 TOOTH ABSCESS 242 0.0237
381 ABDOMINAL PAIN UPPER 4857 0.0236
382 TOOTH DISORDER 523 0.0235
383 SKIN REACTION 331 0.0235
384 RASH PRURITIC 1272 0.0234
385 ENDOCARDITIS 120 0.0234
386 ASTHMA 2640 0.0233
387 ERYSIPELAS 117 0.0233
388 DYSLIPIDAEMIA 118 0.0232
389 ENTEROCOCCAL INFECTION 112 0.0232
390 BRONCHITIS 1709 0.0231
391 PNEUMOCYSTIS JIROVECII PNEUMONIA 231 0.0230
392 ALANINE AMINOTRANSFERASE INCREASED 1403 0.0228
393 STAPHYLOCOCCAL BACTERAEMIA 99 0.0228
394 KLEBSIELLA INFECTION 115 0.0227
395 LEUKOPENIA 1135 0.0227
396 OCULAR DISCOMFORT 254 0.0226
397 UVEITIS 304 0.0224
398 GENERALISED OEDEMA 277 0.0224
399 THERMAL BURN 158 0.0222
400 CYTOMEGALOVIRUS VIRAEMIA 99 0.0222
401 HEPATIC FIBROSIS 76 0.0221
402 FOOT FRACTURE 418 0.0220
403 BACTERAEMIA 261 0.0220
404 HYPERKERATOSIS 121 0.0219
405 GLAUCOMA 421 0.0218
406 BACTERIAL SEPSIS 71 0.0218
407 FUNGAL SKIN INFECTION 88 0.0218
408 DRUG SPECIFIC ANTIBODY PRESENT 141 0.0217
409 ASPARTATE AMINOTRANSFERASE INCREASED 1150 0.0216
410 INJECTION SITE RASH 664 0.0216
411 CHRONIC SINUSITIS 81 0.0216
412 BEDRIDDEN 283 0.0215
413 GASTROENTERITIS VIRAL 387 0.0214
414 PNEUMONIA 6938 0.0214
415 OSTEOPENIA 325 0.0214
416 EAR PRURITUS 75 0.0214
417 VEIN DISORDER 107 0.0214
418 FATIGUE 16641 0.0214
419 PYELONEPHRITIS 185 0.0213
420 ADVERSE EVENT 1967 0.0213
421 FEMUR FRACTURE 661 0.0213
422 AMNESIA 1379 0.0212
423 LIVER FUNCTION TEST ABNORMAL 614 0.0211
424 GAIT DISTURBANCE 4034 0.0211
425 CYTOMEGALOVIRUS INFECTION REACTIVATION 93 0.0210
426 FLUID RETENTION 1067 0.0210
427 MUSCULAR WEAKNESS 2384 0.0210
428 VASCULITIS 243 0.0208
429 PYODERMA GANGRENOSUM 75 0.0208
430 SKIN INFECTION 229 0.0204
431 CELLULITIS 1022 0.0203
432 TENDON DISORDER 132 0.0202
433 ADVERSE DRUG REACTION 1814 0.0202
434 FEAR OF INJECTION 144 0.0202
435 PYREXIA 6961 0.0201
436 RASH ERYTHEMATOUS 957 0.0200
437 CANDIDA INFECTION 338 0.0200
438 PRURITUS 7618 0.0198
439 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 336 0.0198
440 SPINAL DISORDER 187 0.0197
441 SPINAL COMPRESSION FRACTURE 163 0.0197
442 BONE DENSITY DECREASED 614 0.0196
443 ANAPHYLACTIC REACTION 1081 0.0195
444 PARANASAL SINUS DISCOMFORT 74 0.0195
445 SERUM FERRITIN INCREASED 103 0.0195
446 GASTRIC DISORDER 670 0.0195
447 PRODUCT USE IN UNAPPROVED INDICATION 4813 0.0194
448 MALIGNANT MELANOMA 260 0.0194
449 CYSTITIS 617 0.0194
450 MULTIPLE ALLERGIES 151 0.0192
451 LIMB DISCOMFORT 596 0.0192
452 TENDONITIS 297 0.0192
453 MEDICATION ERROR 1063 0.0191
454 VAGINAL INFECTION 90 0.0191
455 ENCEPHALITIS 132 0.0191
456 DISSEMINATED INTRAVASCULAR COAGULATION 268 0.0190
457 LIMB OPERATION 91 0.0190
458 CYTOPENIA 230 0.0188
459 MENINGITIS 125 0.0187
460 IMMUNOSUPPRESSION 165 0.0187
461 TOOTH FRACTURE 206 0.0187
462 EYE INFECTION 211 0.0187
463 SINUS CONGESTION 250 0.0185
464 HYPERAESTHESIA 152 0.0185
465 SKIN WARM 107 0.0184
466 BLOOD PRESSURE INCREASED 2811 0.0184
467 HEAD DISCOMFORT 324 0.0183
468 INJECTION SITE PRURITUS 1225 0.0183
469 POST PROCEDURAL INFECTION 148 0.0182
470 PRODUCT COMPLAINT 461 0.0182
471 KIDNEY INFECTION 357 0.0182
472 PHOTOPHOBIA 342 0.0182
473 ANAL ABSCESS 98 0.0182
474 ORAL DISORDER 133 0.0181
475 GASTROOESOPHAGEAL REFLUX DISEASE 1456 0.0181
476 INSOMNIA 4798 0.0180
477 LYMPHOEDEMA 124 0.0179
478 CARPAL TUNNEL SYNDROME 248 0.0177
479 BACTERIAL INFECTION 330 0.0177
480 ARTHROPOD BITE 131 0.0177
481 SECRETION DISCHARGE 221 0.0176
482 BONE DISORDER 321 0.0176
483 GASTROENTERITIS 256 0.0175
484 GINGIVITIS 94 0.0174
485 MULTIPLE ORGAN DYSFUNCTION SYNDROME 493 0.0174
486 THYROID DISORDER 267 0.0173
487 WHITE BLOOD CELL COUNT DECREASED 1855 0.0171
488 HERPES VIRUS INFECTION 98 0.0170
489 ANKYLOSING SPONDYLITIS 223 0.0169
490 SUBCUTANEOUS ABSCESS 81 0.0169
491 VITAMIN D DECREASED 144 0.0168
492 ENTEROCOLITIS 97 0.0168
493 MEMORY IMPAIRMENT 2305 0.0168
494 ORAL DISCOMFORT 233 0.0167
495 POSTOPERATIVE WOUND INFECTION 113 0.0167
496 TRANSAMINASES INCREASED 371 0.0167
497 TONSILLITIS 87 0.0167
498 OEDEMA PERIPHERAL 2032 0.0167
499 HEADACHE 10431 0.0166
500 WHITE BLOOD CELL COUNT INCREASED 637 0.0166
501 ABSCESS 263 0.0165
502 FUNGAL INFECTION 549 0.0165
503 CHEST PAIN 3034 0.0164
504 DIVERTICULUM 116 0.0163
505 SKIN MASS 109 0.0163
506 LIMB INJURY 443 0.0163
507 BLINDNESS UNILATERAL 229 0.0162
508 SARCOIDOSIS 77 0.0162
509 ECCHYMOSIS 111 0.0162
510 FURUNCLE 128 0.0161
511 OROPHARYNGEAL PAIN 1489 0.0161
512 ACUTE RESPIRATORY DISTRESS SYNDROME 284 0.0160
513 THERAPY PARTIAL RESPONDER 250 0.0160
514 FRACTURE 303 0.0160
515 PSEUDOMONAS INFECTION 137 0.0160
516 MALAISE 6962 0.0159
517 PNEUMOTHORAX 251 0.0158
518 MUSCULOSKELETAL DISCOMFORT 271 0.0157
519 HEPATIC FUNCTION ABNORMAL 579 0.0155
520 CATARACT 917 0.0154
521 ANKLE FRACTURE 238 0.0154
522 PAIN IN JAW 431 0.0152
523 STAPHYLOCOCCAL SEPSIS 75 0.0152
524 PARAESTHESIA 2373 0.0151
525 BLINDNESS 614 0.0151
526 IMPAIRED GASTRIC EMPTYING 205 0.0150
527 SEPSIS 1673 0.0150
528 WEIGHT DECREASED 4178 0.0150
529 NERVE INJURY 166 0.0149
530 COMPRESSION FRACTURE 80 0.0149
531 DIFFUSE LARGE B-CELL LYMPHOMA 115 0.0149
532 QUALITY OF LIFE DECREASED 198 0.0147
533 FREQUENT BOWEL MOVEMENTS 396 0.0146
534 UROSEPSIS 135 0.0146
535 NEPHROLITHIASIS 670 0.0146
536 INTERVERTEBRAL DISC DEGENERATION 135 0.0146
537 ORAL PAIN 326 0.0145
538 PHOTOSENSITIVITY REACTION 240 0.0145
539 VOMITING 6816 0.0145
540 EPSTEIN-BARR VIRUS INFECTION 90 0.0144
541 DECREASED APPETITE 3344 0.0144
542 HAND FRACTURE 102 0.0144
543 TOE AMPUTATION 73 0.0144
544 LABORATORY TEST ABNORMAL 424 0.0144
545 IMMUNE SYSTEM DISORDER 189 0.0143
546 MUSCLE SPASMS 2624 0.0143
547 INFLUENZA 1594 0.0143
548 STRESS FRACTURE 77 0.0143
549 SKIN ATROPHY 82 0.0142
550 SPINAL OSTEOARTHRITIS 125 0.0142
551 PSORIASIS 1850 0.0142
552 PHARYNGITIS STREPTOCOCCAL 153 0.0141
553 DECREASED IMMUNE RESPONSIVENESS 138 0.0140
554 LYMPHOMA 217 0.0140
555 CYTOMEGALOVIRUS INFECTION 233 0.0140
556 GINGIVAL BLEEDING 191 0.0140
557 PLATELET COUNT INCREASED 182 0.0139
558 EYE DISORDER 458 0.0139
559 ORGANISING PNEUMONIA 69 0.0139
560 MATERNAL EXPOSURE BEFORE PREGNANCY 95 0.0139
561 RHINITIS 112 0.0139
562 BLOOD TEST ABNORMAL 195 0.0139
563 HERNIA 268 0.0138
564 MULTIPLE FRACTURES 227 0.0138
565 DRY EYE 686 0.0137
566 ABDOMINAL PAIN 3191 0.0137
567 SPINAL PAIN 160 0.0136
568 NEEDLE ISSUE 397 0.0136
569 BACK PAIN 3166 0.0136
570 RHINORRHOEA 877 0.0136
571 ALTERED STATE OF CONSCIOUSNESS 292 0.0135
572 INCREASED TENDENCY TO BRUISE 124 0.0135
573 URINARY TRACT INFECTION 2298 0.0135
574 DIABETES MELLITUS 1020 0.0134
575 DYSPNOEA 7564 0.0133
576 RESPIRATORY TRACT INFECTION 346 0.0133
577 RASH MACULO-PAPULAR 294 0.0132
578 ASTHENIA 4959 0.0132
579 ROTATOR CUFF SYNDROME 169 0.0131
580 DRUG EFFECT DECREASED 707 0.0131
581 UNDERDOSE 957 0.0131
582 SCRATCH 138 0.0131
583 MENISCUS INJURY 80 0.0130
584 NASAL CONGESTION 763 0.0130
585 ACCIDENT 155 0.0130
586 DIARRHOEA 8375 0.0130
587 VISUAL IMPAIRMENT 1605 0.0129
588 STAPHYLOCOCCAL INFECTION 426 0.0129
589 SPINAL FRACTURE 258 0.0129
590 INTERVERTEBRAL DISC PROTRUSION 280 0.0128
591 INJECTION SITE EXTRAVASATION 158 0.0128
592 GROIN PAIN 111 0.0126
593 GASTROINTESTINAL INFECTION 113 0.0126
594 DEPRESSION 2865 0.0126
595 RECTAL HAEMORRHAGE 539 0.0125
596 NEUTROPHIL COUNT DECREASED 511 0.0125
597 CATARACT OPERATION 74 0.0125
598 MUSCLE STRAIN 107 0.0124
599 TENDON RUPTURE 152 0.0123
600 DENTAL CARIES 136 0.0123
601 COVID-19 2145 0.0122
602 RENAL CYST 97 0.0122
603 SEASONAL ALLERGY 172 0.0121
604 INJECTION SITE SWELLING 931 0.0121
605 PRODUCTIVE COUGH 580 0.0121
606 HYPERTRIGLYCERIDAEMIA 71 0.0121
607 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 662 0.0121
608 SKIN SWELLING 104 0.0120
609 PANCREATITIS 631 0.0119
610 PELVIC FRACTURE 92 0.0118
611 HAEMATEMESIS 298 0.0117
612 INJECTION SITE ERYTHEMA 1455 0.0117
613 TACHYCARDIA 1042 0.0117
614 HEART RATE INCREASED 1156 0.0117
615 RESPIRATORY TRACT CONGESTION 185 0.0116
616 SKIN LESION 319 0.0116
617 HYPOCALCAEMIA 220 0.0116
618 FALL 3865 0.0116
619 CONJUNCTIVITIS 215 0.0116
620 THROMBOCYTOPENIA 1293 0.0116
621 DRUG EFFECT INCOMPLETE 419 0.0115
622 COLITIS ULCERATIVE 514 0.0115
623 VITAMIN D DEFICIENCY 112 0.0115
624 NAUSEA 9037 0.0114
625 STENT PLACEMENT 92 0.0114
626 NEURALGIA 277 0.0114
627 CHOLECYSTITIS 135 0.0113
628 POLYP 74 0.0113
629 UPPER-AIRWAY COUGH SYNDROME 93 0.0113
630 UPPER LIMB FRACTURE 224 0.0112
631 MOVEMENT DISORDER 361 0.0112
632 ORAL CANDIDIASIS 147 0.0112
633 EYE HAEMORRHAGE 148 0.0111
634 NERVE COMPRESSION 102 0.0110
635 DIZZINESS 5507 0.0110
636 CORONAVIRUS INFECTION 73 0.0110
637 NEUTROPHIL COUNT INCREASED 113 0.0110
638 EMPHYSEMA 111 0.0110
639 GASTRIC ULCER 209 0.0110
640 DECUBITUS ULCER 89 0.0109
641 ERYTHEMA 2235 0.0109
642 SYRINGE ISSUE 190 0.0108
643 DEEP VEIN THROMBOSIS 705 0.0108
644 WRIST FRACTURE 130 0.0108
645 DIPLOPIA 281 0.0108
646 LYMPHOPENIA 153 0.0108
647 LUNG INFECTION 168 0.0108
648 RIB FRACTURE 222 0.0108
649 COUGH 3022 0.0108
650 RED BLOOD CELL COUNT DECREASED 308 0.0108
651 ABDOMINAL DISTENSION 1121 0.0107
652 HYPOTHYROIDISM 342 0.0107
653 LYMPHADENOPATHY 378 0.0107
654 ANAPHYLACTIC SHOCK 275 0.0107
655 SPUTUM DISCOLOURED 101 0.0106
656 NEUTROPENIA 1444 0.0106
657 ASCITES 311 0.0106
658 LYMPHOCYTE COUNT DECREASED 185 0.0105
659 HEART RATE IRREGULAR 236 0.0104
660 FEELING HOT 639 0.0104
661 EXPOSURE VIA SKIN CONTACT 269 0.0104
662 VIRAL INFECTION 345 0.0104
663 ILLNESS 1065 0.0103
664 HEPATIC CYTOLYSIS 131 0.0103
665 DERMATITIS 214 0.0102
666 FACIAL PARALYSIS 87 0.0102
667 DEAFNESS 266 0.0102
668 SKIN DISORDER 338 0.0101
669 PRESYNCOPE 246 0.0101
670 THROMBOSIS 806 0.0100
671 PRODUCT STORAGE ERROR 877 0.0100
672 PNEUMONITIS 272 0.0100
673 SPINAL OPERATION 122 0.0099
674 TINNITUS 454 0.0099
675 PULMONARY EMBOLISM 937 0.0098
676 LOW DENSITY LIPOPROTEIN INCREASED 76 0.0098
677 PHARYNGEAL SWELLING 96 0.0098
678 HYPERHIDROSIS 1264 0.0098
679 PRODUCT DOSE OMISSION IN ERROR 277 0.0098
680 SURGERY 570 0.0097
681 SARS-COV-2 TEST POSITIVE 127 0.0096
682 AORTIC ANEURYSM 73 0.0096
683 PHARYNGEAL OEDEMA 147 0.0095
684 EYE INFLAMMATION 91 0.0095
685 ACUTE RESPIRATORY FAILURE 183 0.0095
686 HIATUS HERNIA 123 0.0095
687 CARDIAC MURMUR 82 0.0095
688 HIP FRACTURE 304 0.0094
689 GINGIVAL PAIN 75 0.0094
690 APPENDICITIS 88 0.0094
691 THROAT IRRITATION 420 0.0094
692 BLOOD CREATININE INCREASED 600 0.0092
693 KNEE OPERATION 90 0.0091
694 CHOLELITHIASIS 300 0.0091
695 NEOPLASM 105 0.0091
696 INTENTIONAL PRODUCT MISUSE 799 0.0091
697 BLOOD POTASSIUM INCREASED 148 0.0091
698 MUSCULOSKELETAL CHEST PAIN 141 0.0091
699 BLOOD IRON DECREASED 108 0.0091
700 TUMOUR LYSIS SYNDROME 80 0.0091
701 EYE PAIN 513 0.0091
702 FLANK PAIN 85 0.0091
703 SLEEP APNOEA SYNDROME 173 0.0091
704 INJECTION SITE URTICARIA 222 0.0090
705 HYPERTENSIVE CRISIS 100 0.0090
706 HAEMATOCRIT DECREASED 178 0.0090
707 BURNING SENSATION 628 0.0089
708 HYPOTENSION 1789 0.0089
709 NEOPLASM MALIGNANT 595 0.0089
710 PLEURAL EFFUSION 541 0.0089
711 RESPIRATORY FAILURE 643 0.0088
712 OVARIAN CYST 88 0.0088
713 HEPATOMEGALY 86 0.0087
714 RENAL IMPAIRMENT 732 0.0087
715 HYPERLIPIDAEMIA 104 0.0087
716 PLATELET COUNT DECREASED 925 0.0087
717 DRY THROAT 88 0.0086
718 CHILLS 1009 0.0086
719 PULMONARY CONGESTION 113 0.0086
720 BLOOD TRIGLYCERIDES INCREASED 151 0.0085
721 LOSS OF CONSCIOUSNESS 1094 0.0085
722 HYPOKALAEMIA 394 0.0085
723 FEEDING DISORDER 172 0.0085
724 INJECTION SITE DISCOLOURATION 105 0.0084
725 DEVICE RELATED INFECTION 128 0.0083
726 EMBOLISM 69 0.0083
727 ESCHERICHIA INFECTION 68 0.0083
728 HAEMOGLOBIN DECREASED 848 0.0083
729 ATELECTASIS 79 0.0082
730 IMPAIRED QUALITY OF LIFE 117 0.0081
731 IRON DEFICIENCY ANAEMIA 75 0.0081
732 HAEMATURIA 278 0.0081
733 HEPATOCELLULAR INJURY 115 0.0081
734 MYALGIA 1371 0.0081
735 OPTIC NEURITIS 73 0.0080
736 CLOSTRIDIUM DIFFICILE INFECTION 175 0.0080
737 EPISTAXIS 594 0.0079
738 HYPOXIA 276 0.0078
739 BRAIN NEOPLASM 72 0.0078
740 PERITONITIS 162 0.0078
741 ANXIETY 2225 0.0078
742 INTERNAL HAEMORRHAGE 89 0.0078
743 FULL BLOOD COUNT ABNORMAL 82 0.0077
744 PRODUCT QUALITY ISSUE 1053 0.0077
745 DRUG RESISTANCE 199 0.0077
746 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 73 0.0076
747 SKIN CANCER 164 0.0076
748 SPLENOMEGALY 89 0.0076
749 COLON CANCER 113 0.0076
750 TOOTH EXTRACTION 94 0.0075
751 LACERATION 71 0.0075
752 CARDIO-RESPIRATORY ARREST 315 0.0075
753 APHONIA 105 0.0075
754 THERAPY INTERRUPTED 531 0.0074
755 SCAR 127 0.0074
756 SWELLING FACE 483 0.0074
757 INJECTION SITE IRRITATION 94 0.0074
758 DYSPHONIA 431 0.0074
759 GASTROINTESTINAL PAIN 81 0.0074
760 INJECTION SITE WARMTH 151 0.0073
761 NEUROTOXICITY 128 0.0073
762 PRODUCT DOSE OMISSION ISSUE 2143 0.0073
763 FOETAL EXPOSURE DURING PREGNANCY 591 0.0073
764 SUBARACHNOID HAEMORRHAGE 74 0.0073
765 SYNCOPE 724 0.0072
766 INJECTION SITE BRUISING 577 0.0072
767 DISEASE PROGRESSION 852 0.0072
768 SNEEZING 161 0.0072
769 PANCREATITIS ACUTE 161 0.0072
770 EOSINOPHILIA 124 0.0071
771 COLITIS 268 0.0071
772 SKIN DISCOLOURATION 324 0.0070
773 BLADDER DISORDER 70 0.0070
774 HYPERBILIRUBINAEMIA 73 0.0070
775 SCAB 80 0.0070
776 CEREBRAL INFARCTION 171 0.0070
777 PANCYTOPENIA 391 0.0070
778 AGRANULOCYTOSIS 130 0.0070
779 PERIPHERAL COLDNESS 96 0.0070
780 HAEMORRHOIDS 136 0.0070
781 PROTEINURIA 132 0.0069
782 ANGINA PECTORIS 198 0.0069
783 REBOUND EFFECT 78 0.0069
784 LOCAL SWELLING 119 0.0068
785 ABDOMINAL PAIN LOWER 172 0.0068
786 COMA 323 0.0068
787 MYELODYSPLASTIC SYNDROME 98 0.0068
788 INTENTIONAL DOSE OMISSION 191 0.0067
789 BLOOD URINE PRESENT 127 0.0067
790 GOUT 120 0.0067
791 HAEMATOMA 173 0.0067
792 ATRIAL FIBRILLATION 650 0.0067
793 BRONCHOSPASM 95 0.0067
794 GASTRITIS 174 0.0066
795 DEVICE MALFUNCTION 458 0.0065
796 SWOLLEN TONGUE 203 0.0065
797 PULMONARY OEDEMA 288 0.0064
798 RENAL DISORDER 299 0.0064
799 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 298 0.0064
800 THERAPEUTIC RESPONSE SHORTENED 211 0.0064
801 CARDIOVASCULAR DISORDER 160 0.0063
802 INJECTION SITE INDURATION 81 0.0062
803 PRODUCT DOSE OMISSION 407 0.0062
804 LUNG NEOPLASM MALIGNANT 254 0.0062
805 PRODUCT PREPARATION ERROR 126 0.0061
806 SINUS DISORDER 121 0.0061
807 SHOCK 139 0.0060
808 ENCEPHALOPATHY 148 0.0060
809 MYOCARDITIS 69 0.0060
810 DYSPNOEA EXERTIONAL 226 0.0060
811 INCORRECT PRODUCT ADMINISTRATION DURATION 129 0.0059
812 BREAST CANCER 551 0.0059
813 RENAL FAILURE 777 0.0058
814 CARDIAC FAILURE 466 0.0058
815 HYPOKINESIA 84 0.0058
816 RESTLESS LEGS SYNDROME 105 0.0058
817 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 300 0.0057
818 LEUKOCYTOSIS 104 0.0057
819 PRODUCT ADMINISTRATION ERROR 116 0.0057
820 SKIN FISSURES 112 0.0057
821 GAMMA-GLUTAMYLTRANSFERASE INCREASED 127 0.0057
822 GALLBLADDER DISORDER 102 0.0057
823 DEVICE ISSUE 512 0.0057
824 DIABETES MELLITUS INADEQUATE CONTROL 101 0.0057
825 MUSCLE TIGHTNESS 92 0.0057
826 BLOOD PRESSURE DECREASED 377 0.0057
827 HAEMOPTYSIS 158 0.0057
828 BLOOD BILIRUBIN INCREASED 153 0.0057
829 HAEMATOCHEZIA 312 0.0056
830 MYOCARDIAL INFARCTION 975 0.0056
831 PERICARDIAL EFFUSION 129 0.0056
832 HOT FLUSH 419 0.0056
833 DISEASE RECURRENCE 264 0.0055
834 PRURITUS GENERALISED 120 0.0055
835 POST PROCEDURAL COMPLICATION 106 0.0055
836 VERTIGO 335 0.0055
837 THROAT TIGHTNESS 148 0.0055
838 RETCHING 116 0.0054
839 SENSORY DISTURBANCE 87 0.0054
840 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 158 0.0054
841 HUNGER 75 0.0054
842 CONSTIPATION 1169 0.0054
843 BRAIN FOG 84 0.0054
844 PULMONARY HYPERTENSION 111 0.0053
845 HEAD INJURY 168 0.0053
846 CHEST DISCOMFORT 542 0.0053
847 FEELING COLD 146 0.0052
848 PRODUCT DISPENSING ERROR 114 0.0052
849 MUCOSAL INFLAMMATION 137 0.0052
850 THERAPY CESSATION 268 0.0052
851 PREMATURE DELIVERY 83 0.0052
852 ISCHAEMIC STROKE 93 0.0052
853 PRODUCT PRESCRIBING ERROR 122 0.0051
854 BONE MARROW FAILURE 104 0.0051
855 ANAEMIA 976 0.0051
856 HYPOACUSIS 220 0.0051
857 ACCIDENTAL EXPOSURE TO PRODUCT 526 0.0051
858 INFLUENZA LIKE ILLNESS 419 0.0051
859 PALPITATIONS 593 0.0051
860 HOSPITALISATION 777 0.0051
861 UNEVALUABLE EVENT 382 0.0050
862 CRYING 183 0.0050
863 DYSSTASIA 147 0.0050
864 INJECTION SITE MASS 186 0.0050
865 LACRIMATION INCREASED 149 0.0049
866 CARDIAC DISORDER 461 0.0049
867 BLOOD ALKALINE PHOSPHATASE INCREASED 122 0.0049
868 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 883 0.0049
869 HAEMORRHAGE 506 0.0048
870 BLOOD UREA INCREASED 81 0.0048
871 DRUG EFFECT LESS THAN EXPECTED 71 0.0048
872 SOMNOLENCE 964 0.0048
873 LIP SWELLING 159 0.0048
874 BONE PAIN 275 0.0047
875 ACUTE MYOCARDIAL INFARCTION 138 0.0047
876 MIDDLE INSOMNIA 87 0.0047
877 RESPIRATORY DISTRESS 128 0.0046
878 ACUTE KIDNEY INJURY 709 0.0046
879 PELVIC PAIN 84 0.0046
880 TRANSIENT ISCHAEMIC ATTACK 155 0.0046
881 MELAENA 101 0.0046
882 ACNE 347 0.0046
883 CEREBROVASCULAR ACCIDENT 770 0.0045
884 ANGIOEDEMA 201 0.0045
885 TREATMENT NONCOMPLIANCE 247 0.0045
886 OVERDOSE 971 0.0045
887 NEUROPATHY PERIPHERAL 428 0.0045
888 ARRHYTHMIA 212 0.0045
889 URINARY INCONTINENCE 132 0.0045
890 FEELING ABNORMAL 1063 0.0044
891 BLOOD PRESSURE ABNORMAL 86 0.0043
892 CEREBRAL HAEMORRHAGE 154 0.0043
893 BLOOD POTASSIUM DECREASED 129 0.0043
894 POOR QUALITY SLEEP 92 0.0043
895 DEMENTIA 119 0.0043
896 PNEUMONIA ASPIRATION 106 0.0042
897 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 109 0.0042
898 OSTEONECROSIS 139 0.0042
899 DYSURIA 153 0.0042
900 HEPATIC FAILURE 125 0.0041
901 BLOOD CREATINE PHOSPHOKINASE INCREASED 119 0.0041
902 VISION BLURRED 567 0.0041
903 NERVOUS SYSTEM DISORDER 127 0.0041
904 PALLOR 109 0.0040
905 TREMOR 663 0.0040
906 OCULAR HYPERAEMIA 188 0.0040
907 DYSPHAGIA 373 0.0039
908 EMOTIONAL DISORDER 121 0.0039
909 EYE SWELLING 146 0.0039
910 FULL BLOOD COUNT DECREASED 79 0.0039
911 CHOLESTASIS 75 0.0039
912 FEELING JITTERY 73 0.0038
913 PRODUCT PRESCRIBING ISSUE 83 0.0038
914 APHASIA 114 0.0038
915 ECZEMA 197 0.0038
916 ACTIVITIES OF DAILY LIVING IMPAIRED 74 0.0037
917 RASH MACULAR 128 0.0037
918 FLUSHING 372 0.0037
919 CHROMATURIA 82 0.0036
920 DRUG INTERACTION 576 0.0036
921 INCREASED APPETITE 69 0.0036
922 MYELOSUPPRESSION 130 0.0036
923 FLATULENCE 204 0.0036
924 POLLAKIURIA 149 0.0036
925 CARDIAC ARREST 292 0.0035
926 INJECTION SITE PAIN 1083 0.0035
927 PROCEDURAL PAIN 97 0.0035
928 INJURY ASSOCIATED WITH DEVICE 70 0.0034
929 BRADYCARDIA 182 0.0034
930 BALANCE DISORDER 295 0.0034
931 PREMATURE BABY 101 0.0034
932 HYPERGLYCAEMIA 121 0.0033
933 CARDIAC FAILURE CONGESTIVE 266 0.0033
934 EYE PRURITUS 110 0.0033
935 ABASIA 80 0.0032
936 URINARY RETENTION 108 0.0032
937 DEPRESSED MOOD 171 0.0032
938 SPEECH DISORDER 168 0.0032
939 GASTROINTESTINAL HAEMORRHAGE 266 0.0032
940 FEBRILE NEUTROPENIA 211 0.0032
941 DRY SKIN 412 0.0031
942 DEHYDRATION 410 0.0031
943 INTESTINAL OBSTRUCTION 113 0.0030
944 PANIC ATTACK 109 0.0030
945 DEATH 2546 0.0030
946 EYE IRRITATION 168 0.0029
947 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 591 0.0029
948 NERVOUSNESS 152 0.0029
949 ABORTION SPONTANEOUS 116 0.0029
950 MOOD SWINGS 91 0.0029
951 HYPOGLYCAEMIA 138 0.0028
952 HYPERSOMNIA 80 0.0028
953 MOOD ALTERED 76 0.0028
954 SEIZURE 319 0.0028
955 MENTAL DISORDER 120 0.0028
956 PAIN OF SKIN 74 0.0027
957 HYPONATRAEMIA 154 0.0027
958 JAUNDICE 73 0.0027
959 SKIN IRRITATION 124 0.0027
960 PANCREATIC CARCINOMA 76 0.0026
961 LETHARGY 151 0.0026
962 INJECTION SITE HAEMORRHAGE 204 0.0026
963 DEVICE DIFFICULT TO USE 168 0.0025
964 BLOOD GLUCOSE INCREASED 474 0.0025
965 ELECTROCARDIOGRAM QT PROLONGED 85 0.0024
966 LACTIC ACIDOSIS 74 0.0023
967 SKIN EXFOLIATION 191 0.0023
968 TOXICITY TO VARIOUS AGENTS 369 0.0022
969 CHRONIC KIDNEY DISEASE 166 0.0022
970 COGNITIVE DISORDER 101 0.0022
971 DRUG DEPENDENCE 345 0.0021
972 MULTIPLE SCLEROSIS 101 0.0021
973 HYPERKALAEMIA 74 0.0021
974 MALIGNANT NEOPLASM PROGRESSION 204 0.0020
975 BLOOD GLUCOSE DECREASED 91 0.0019
976 HALLUCINATION 141 0.0019
977 SUICIDAL IDEATION 170 0.0019
978 PROSTATE CANCER 147 0.0018
979 DYSGEUSIA 135 0.0018
980 DEVICE DISLOCATION 79 0.0018
981 DISORIENTATION 69 0.0017
982 DRUG DOSE OMISSION 282 0.0017
983 THERAPEUTIC RESPONSE UNEXPECTED 74 0.0016
984 DISTURBANCE IN ATTENTION 82 0.0015
985 SKIN BURNING SENSATION 106 0.0015
986 INCORRECT DOSE ADMINISTERED 329 0.0014
987 AGITATION 105 0.0014
988 IRRITABILITY 80 0.0013
989 BLADDER CANCER 71 0.0012